Search alternatives:
significant barriers » significant barrier (Expand Search), significant factors (Expand Search), significant burden (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
barriers decrease » larger decrease (Expand Search), barrier disease (Expand Search)
significant barriers » significant barrier (Expand Search), significant factors (Expand Search), significant burden (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
barriers decrease » larger decrease (Expand Search), barrier disease (Expand Search)
-
3561
PAS staining images of pathological changes in renal tissues among 4 groups (×400).
Published 2024Subjects: -
3562
-
3563
-
3564
Comparison of mTOR expression grading among different groups at different time points.
Published 2024Subjects: -
3565
-
3566
a) Number weighted mean volume of AEII during postnatal development and in adults. There are no volume alterations before and at the end of bulk alveolarization. A significant increase was determined in adults compared to 3 and 7 days old pups. b) Size of AEII presented as V<sub>S</sub>-ratioAEII during postnatal lung development into adulthood. Before and during bulk alveolarization there are no size changes. Adults show a significant increase compared to values before and at onset of alveolarization. c) Number weighted mean volume of AEII per lung volume during postnatal development and in adults. The highest values are seen before alveolarization. During alveolarization the quotient decreases and reaches significance compared to 3 days old pups at postnatal day 21....
Published 2025“…During alveolarization the quotient decreases and reaches significance compared to 3 days old pups at postnatal day 21. …”
-
3567
-
3568
Frequency distribution of SOLEC at baseline and follow-ups in WAD grade 2 and WAD grade 3.
Published 2024Subjects: -
3569
-
3570
-
3571
-
3572
Line graph showing the values of inflammatory cytokines at baseline and after treatment.
Published 2025Subjects: -
3573
Baseline descriptive characteristics of trial participants (n = 140) with and without dizziness.
Published 2024Subjects: -
3574
-
3575
-
3576
-
3577
-
3578
Frequency distribution of SOLEC at baseline and follow-ups in the NSEIT and NSE groups.
Published 2024Subjects: -
3579
-
3580
Baseline and Post-Treatment Results of Echocardiographic Variables in Each Experimental Group.
Published 2025Subjects: